Skip to content

Author

McKenzie L. Schaefer

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Time Toxicity and End-of-Life Treatment of Metastatic Pancreatic Cancer.

Patients with metastatic PDAC spend roughly 1 in 5 days of survival engaged in health care interactions, creating substantial time toxicity-the time patients spend engaged with the health care system.

Patrick L. Quinn, M. Schaefer, Aslam M. Ejaz · 0 citations
Review Open access Sep 2026

The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer.

BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy with limited long-term survival despite advances in surgery and systemic therapy. PATIENTS The population of interest comprises patients with PDAC characterized by targetable molecular alterations and biologically distinct transcrip...

McKenzie L. Schaefer, Susan Tsai, Alex B. Blair · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.